Clinical Significance:This test detects the factor V Leiden variant, the most common cause of inherited thrombophilia; it may be used to evaluate individuals with a strong personal or family history of venous thromboembolism (VTE) and inform treatment or preventive decisions [1]. Factor V Leiden r...
(redirected fromFactor V Leiden mutation) Thesaurus Medical Legal Acronyms Encyclopedia mu·ta·tion (myo͞o-tā′shən) n. 1.The act or process of being altered or changed. 2.An alteration or change, as in nature, form, or quality. ...
The factor V Leiden mutation is a recently described autosomal dominant genetic risk factor for venous thromboembolism (VTE). Persons who are heterozygous or homozygous for this disorder are at 4 to 7 times and 50 to 100 times increased risk, respectively, for VTE. In particular, women have ...
Synonyms for Factor V Leiden mutation in Free Thesaurus. Antonyms for Factor V Leiden mutation. 34 synonyms for mutation: anomaly, variation, deviant, freak of nature, change, variation, evolution, transformation, modification, alteration, deviation...
遗传阻断导读:Factor V Leiden易栓症是一种儿科疾病。佳学基因对Factor V Leiden易栓症的发生进行了基因解码,并将之收入《人的基因序列变化与人体疾病表征》中,便于医生选择和使用,进行Factor V Leiden易栓症遗传阻断,也便于患者更好地进行治疗和健康管理。
Factor V Leiden 第五凝血因子；莱登第五因子 第五凝血因子 检验第五凝血因子(Factor V leiden)上的G1691A突变：造成容易产生血栓的体质(血栓病, thrombophilia)。北美洲有 5% 的人遗传有莱登第五因子 ( Factor V Leiden )﹐影响凝血功能。 年长﹑肥胖﹑抽烟﹐与及曾经出现过静脉栓塞症状的人士﹐再次...
Aim. Lebanon exhibits one of the highest prevalences of factor V-Leiden (FVL) in the world (14.4%). The aim of this study is to evaluate the incidence of FVL mutation among Lebanese patients with lower extremity venous thrombosis. Material and Methods. From January 2003 to January 2011, 28...
摘要: Factor V Leiden mutation is a risk factor for the development of thrombo-embolic episodes in pregnancy. A case is presented of a pregnant woman with repeated episodes of venous thrombosis with a complicated clinical course.关键词: Leiden mutation Pregnancy Thrombotic episodes ...
Factor V Leiden mutation is a common genetic risk factor for venous thrombosis. It has been documented in up to 65% of patients with unexplained venous thromboembolism. This genetic mutation is now known to be the most common inherited cause of activated protein C (APC) resistance. Recently, ...
factor V Leiden mutation and hereditary protein C deficiency appear to be important risk factors for BCS and PVT. Although the prevalence of the prothrombin gene muta- tion was increased, it was not found to be a significant risk factor for BCS and PVT. The coexistence of thrombogenic...